P. Boer
- Physiology top 5%
- Adenosine and Purinergic Signaling 7
- Infectious Diseases top 10%
- HIV/AIDS drug development and treatment 11
-
- Biochemical and Molecular Research 31
-
- Metabolism and Genetic Disorders 8
-
- Cytomegalovirus and herpesvirus research 9
-
- Neonatal Health and Biochemistry 8
-
- Blood disorders and treatments 4
-
- Glycogen Storage Diseases and Myoclonus 3
- Co-authors
- Oded SperlingAndré de VriesBianka LipsteinDe Vries AEsther Zoref‐ShaniDon R. PhillipsNataly TarasenkoGania Kessler‐Icekson
In The Last Decade
P. Boer
34 papers receiving 395 citations
Peers
Comparison fields: 5 of 57
- Physiology 83
- Infectious Diseases 129
- Molecular Biology 365
- Clinical Biochemistry 34
- Epidemiology 168
Countries citing papers authored by P. Boer
This map shows the geographic impact of P. Boer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Boer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Boer more than expected).
Fields of papers citing papers by P. Boer
This network shows the impact of papers produced by P. Boer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Boer. The network helps show where P. Boer may publish in the future.
Co-authorship network
The 23 scholars most cited alongside P. Boer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 33 | |
| 2 | 2004 | 2 | |
| 3 | 2001 | 17 | |
| 4 | 2000 | 13 | |
| 5 | 1998 | 1 | |
| 6 | 1995 | 13 | |
| 7 | 1991 | 2 | |
| 8 | 1991 | 3 | |
| 9 | 1991 | 5 | |
| 10 | 1986 | 3 | |
| 11 | De novo synthesis of purine nucleotides and metabolic availability of phosphoribosylpyrophosphate in leukemic leukocytes. | 1979 | 4 |
| 12 | Urinary xanthine stones in an allopurinol-treated gouty patient with partial deficiency of hypoxanthine-guanine phosphoribosyltransferase. | 1978 | 3 |
| 13 | 1977 | 4 | |
| 14 | 1976 | 38 | |
| 15 | 1976 | 41 | |
| 16 | 1975 | 1 | |
| 17 | 1974 | 4 | |
| 18 | Altered kinetic property of erythrocyte phosphoribosylpsyrophosphate synthetase in excessive purine production. | 1973 | 52 |
| 19 | Evidence for molecular alteration of erythrocyte hypoxanthine-guanine phosphoribosyltransferase in a gouty family with partial deficiency of the enzyme. | 1972 | 7 |
| 20 | 1972 | 6 |
About P. Boer
P. Boer is a scholar working on Physiology, Clinical Biochemistry, Infectious Diseases, Molecular Biology and Pediatrics, Perinatology and Child Health, having authored 35 papers that have together received 413 indexed citations. Recurring topics across this work include Biochemical and Molecular Research (31 papers), HIV/AIDS drug development and treatment (11 papers), Cytomegalovirus and herpesvirus research (9 papers), Metabolism and Genetic Disorders (8 papers), Neonatal Health and Biochemistry (8 papers), Adenosine and Purinergic Signaling (7 papers), Blood disorders and treatments (4 papers) and Glycogen Storage Diseases and Myoclonus (3 papers). The work is most often cited by research in Physiology (83 citations), Infectious Diseases (129 citations), Molecular Biology (365 citations), Clinical Biochemistry (34 citations) and Epidemiology (168 citations). P. Boer has collaborated with scholars based in Israel and Australia. Frequent co-authors include Oded Sperling, André de Vries, Bianka Lipstein, De Vries A, Esther Zoref‐Shani, Don R. Phillips, Nataly Tarasenko, Gania Kessler‐Icekson, Aida Inbal and Abraham Nudelman. Their work appears in journals such as Advances in experimental medicine and biology, Biochimica et Biophysica Acta (BBA) - General Subjects, Annals of Nutrition and Metabolism, Investigational New Drugs and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.